A Phase 1/2, Study of Adjuvant Immunotherapy with EVX-02 and Anti-PD-1 after Complete Resection of Stage IIIB/IIIC/IIID or Stage IV Melanoma in Patients at High Risk for Recurrence

Project: Research

Project Details

StatusActive
Effective start/end date7/08/206/08/25

Keywords

  • clinical trial
  • treatment efficacy
  • treatment safety
  • melanoma